McKinley chooses Baxter for pump distribution:
This article was originally published in Clinica
Baxter is to distribute McKinley's WalkMed line of ambulatory infusion pumps and disposables outside the US. The exclusive agreement is for five years. US company McKinley says its infusion pumps are the US market leaders for use by oncologists. The product complements Baxter's own range of disposable ambulatory infusion pumps.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.